Legal Representation
Attorney
Michael J. Leonard
USPTO Deadlines
Next Deadline
1722 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241008)
Due Date
October 08, 2030
Grace Period Ends
April 08, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 8, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 8, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 1, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Sep 1, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 18, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 5, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 18, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 5, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 5, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 10, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 10, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 20, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 1, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 1, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 1, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 1, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 31, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 22, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 22, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
First Use Anywhere:
Feb 13, 2024
First Use in Commerce:
Feb 13, 2024
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"XR"